Small-cell carcinoma in the setting of pulmonary adenocarcinoma: new insights in the era of molecular pathology.
about
Small-Cell Lung Cancer Transformation in Patients With Pulmonary Adenocarcinoma: A Case Report and Review of LiteratureOrigins, genetic landscape, and emerging therapies of small cell lung cancerMolecular testing in lung cancer in the era of precision medicineTransformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of originHistopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumorsPatients harboring ALK rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case reportEpidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literatureDe novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors.Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases.Synchronous primary lung cancer presenting with small cell carcinoma and adenocarcinomaGenetic alterations and protein expression in combined small cell lung cancers and small cell lung cancers arising from lung adenocarcinomas after therapy with tyrosine kinase inhibitors.Evolution from genetics to phenotype: reinterpretation of NSCLC plasticity, heterogeneity, and drug resistance.Small cell lung cancer transformation during immunotherapy with nivolumab: A case report.Secondary biopsy of non-oncogenic-driven lung cancer may reveal a clinically sensible histologic change. A brief report of two paradigmatic cases.Molecular mechanisms of pathological tumor transformation and their clinical implications: predictors of pulmonary adenocarcinoma transformation into small cell carcinoma.Small-cell transformation of ALK-rearranged non-small-cell adenocarcinoma of the lung.Histological evolution from primary lung adenocarcinoma harboring EGFR mutation to high-grade neuroendocrine carcinoma.Histological transformation after acquired resistance to epidermal growth factor tyrosine kinase inhibitors.[Advances in the Transformation to Small Cell Lung Cancer from Non-small Cell Lung Cancer Following Acquired Drug-resistance to EGFR Tyrosine Kinase Inhibitors].Transformation to small-cell lung cancer following treatment with icotinib in a patient with lung adenocarcinoma.Histological transformation of adenocarcinoma to small cell carcinoma lung as a rare mechanism of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors: Report of a case with review of literature.Small cell lung cancer transformation from EGFR-mutated lung adenocarcinoma: A case report and literatures review.[Clinical Observation of Translating to Small Cell Lung Cancer Following Treatment with EGFR-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma].EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients.
P2860
Q26766283-57319F26-C483-444F-9806-8AF3E07B6936Q26798218-610D68D5-24AF-47E4-93F3-7A7D6F676E7AQ26824599-B96590E7-F81A-4902-A313-63B36CEEE616Q26826437-D61C22A7-763F-4E05-AEB2-9CA4B482D5A5Q28077504-336A38BB-0E97-4AAA-A5A3-7500572D87C9Q33879174-21929970-5AC6-4D7D-BFBC-B76C8A35DA43Q33925170-F71D076B-609B-4F4E-B20B-9F59FCEB14C6Q35164473-ABBF0D02-931F-469E-B92A-BEB78F82CEA7Q37133262-EA4E86FB-0B2B-4738-95E0-F9B19D555409Q37187217-FDDEF4EE-0ED2-4648-838A-D051E5E0317FQ37376246-EECE2108-406B-4641-AEAC-2EF8101767A3Q37666880-A4632716-51FD-4F86-A467-11096839BD30Q37733355-DE08A905-1E0A-4A34-BECC-003553D76C9FQ40980773-046390CD-EB47-41C0-A294-B4AD697D4FE3Q47120303-00C194B3-343E-4551-A109-70A3C163882DQ47215959-2B1929D9-913E-408D-878B-DC40F106753FQ47626957-C7AB06B6-97A3-49BB-BF94-680AD77C2D22Q48354758-E1EE389F-61B3-47A1-AE45-B778EDB20517Q50072136-AE6F50D2-BD30-44FD-BC22-749B893EE108Q51733149-F11A66F7-71FB-4615-823B-C7CC60973B3BQ52682448-C4DE598C-9F4F-4489-8DE0-316907E773A6Q53707746-B437FE55-8264-46DC-A62C-8300D0BCB6FBQ53813022-C847D252-5CEA-4C75-8F0D-C5D913E81584Q54222458-987DC72E-F37D-41C4-B36C-F24E3A103ABB
P2860
Small-cell carcinoma in the setting of pulmonary adenocarcinoma: new insights in the era of molecular pathology.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Small-cell carcinoma in the se ...... he era of molecular pathology.
@en
Small-cell carcinoma in the se ...... he era of molecular pathology.
@nl
type
label
Small-cell carcinoma in the se ...... he era of molecular pathology.
@en
Small-cell carcinoma in the se ...... he era of molecular pathology.
@nl
prefLabel
Small-cell carcinoma in the se ...... he era of molecular pathology.
@en
Small-cell carcinoma in the se ...... he era of molecular pathology.
@nl
P2093
P50
P1476
Small-cell carcinoma in the se ...... he era of molecular pathology.
@en
P2093
Emma Norkowski
Ludovic Lacroix
Maria-Rosa Ghigna
Philippe Dartevelle
Élie Fadel
P304
P356
10.1097/JTO.0B013E3182A407FA
P577
2013-10-01T00:00:00Z